Implications of anaemia and response to anaemia treatment on outcomes in patients with cirrhosis.
JHEP Rep
; 5(4): 100688, 2023 Apr.
Article
em En
| MEDLINE
| ID: mdl-36926273
ACLF, acute-on-chronic liver failure; AIH, autoimmune hepatitis; ALT, alanine aminotransferase; AP, alkaline phosphatase; AST, aspartate aminotransferase; CRP, C-reactive protein; Haemoglobin; INR, international normalised ratio; Iron deficiency; Iron supplementation; LT, liver transplantation; Liver transplantation; MELD, model for end-stage liver disease; NASH, non-alcoholic steatohepatitis; NSBBs, non-selective beta blockers; PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; Rifaximin; SSC, secondary sclerosing cholangitis; TIPS, transjugular intrahepatic portosystemic shunt; aPTT, activated partial thromboplastin time; ΔHb3, difference of haemoglobin levels after 3 months; ΔHb6, difference of haemoglobin levels after 6 months
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
JHEP Rep
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Alemanha